Download the files in the language of your choice
Instructions for Use
Product Specifications


VertiGRAFT® ACIS VG2™ Bio-Implant designed with two cortical endplates supporting a cancellous center for ACDF Procedures.

  • Proven Clinical Performance: The cortical cancellous design optimizes strength and clinical success. A prospective study found 100% fusion rates after 12 months in 74 ACDF Patients.1
  • Osteoconductive: Large cancellous matrix facilitates bone growth and remodeling in accordance with Wolff’s Law.
  • Stability: Textured surface and multiple footprints optimize fit and fill while reducing migration.
  • Sagittal Balance: Available in both neutral and lordotic footprints to reproduce and correct the anatomy.
  • Convenience: Preservon® is a proprietary, glycerol-based preservation technology that allows LifeNet Health allograft implants to be stored in a fully hydrated state at ambient temperature. Lengthy thawing or rehydration time is eliminated with out compromising allograft strength.2
  • Sterile: Sterilized using proprietary and patented Allowash XG® technology. This technology provides a sterility assurance level of 10-6, without compromising the implants inherent osteoconductive properties.3
  1. Abla A, El Kadi H, Bost J, Maroon J, and Wert M. Allograft Composite Cortical and Cancellous Bone Graft for Anterior Cervical Fusion. Contemporary Neurosurgery: A Biweekly Publication for Clinical Neurosurgical Continuing Medical Education. 2005;27(8):1-6.
  2. Independent sources include Virginia Commonwealth University Medical Center and the American Association of Mechanical Engineers. Data on File at LifeNet Health, Virginia Beach VA.
  3. Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG” 2007 BioImplants Brief
    VG2® Cervical Allograft Spacer and VG1® Cervical Allograft Spacer